Study compares tests' identification of subtle cognitive changes

10/17/2013 | MedPage Today (free registration)

An Eli Lilly & Co. study of people with cognitive impairment found the Montreal Cognitive Assessment was better at identifying subtle cognitive differences in patients with mild impairment than the Mini-Mental State Examination. Discerning small cognitive differences in patients has become important as clinical trials for Alzheimer's disease drugs target people with mild impairment or normal but high-risk patients. The study was presented at the American Neurological Association annual meeting.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA